To determine if the observed effects in patients are causally related to the loss of ATG12-expression and not to the loss of other genes located in the same chromosomal region, we engineered the HNSCC cell line, UTSCC5, with ATG12-inducible (doxycycline) knockdown. This evidence concerns the gene ATG12 and head and neck squamous cell carcinoma.